FDA Clears GenesisX Robotic Magnetic Navigation System for Minimally Invasive Endovascular Interventions

Stereotaxis has received FDA clearance for its GenesisX robotic magnetic navigation system, which features a compact design and operates on standard power. The system allows for easy installation in existing cath labs without complex architectural planning or construction. GenesisX is the latest advance in endovascular surgical robotics and has the potential to increase accessibility and scalability of Robotic Magnetic Navigation. Stereotaxis has initiated a limited launch in the US and Europe and plans to expand its portfolio of compatible catheters and enhance commercial processes.